======= PHF17 ======= == Gene Information == * **Official Symbol**: JADE1 * **Official Name**: jade family PHD finger 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79960|79960]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6IE81|Q6IE81]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PHF17&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHF17|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610514|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |EPL1| |PHD| |histone H4-K12 acetylation| |histone H4-K8 acetylation| |histone H4-K5 acetylation| |histone H4-K16 acetylation| |histone acetyltransferase complex| |histone H3 acetylation| |histone H4 acetylation| |negative regulation of G1/S transition of mitotic cell cycle| |negative regulation of cell cycle G1/S phase transition| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |ciliary basal body| |protein acetylation| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |negative regulation of canonical Wnt signaling pathway| |negative regulation of cell growth| |protein acylation| |negative regulation of Wnt signaling pathway| |negative regulation of mitotic cell cycle phase transition| |negative regulation of cell cycle phase transition| |negative regulation of growth| |regulation of canonical Wnt signaling pathway| |transcription coactivator activity| |negative regulation of mitotic cell cycle| |peptidyl-lysine modification| |negative regulation of cell cycle process| |regulation of Wnt signaling pathway| |histone modification| |covalent chromatin modification| |nuclear speck| |regulation of mitotic cell cycle phase transition| |regulation of cell growth| |regulation of cell cycle phase transition| |negative regulation of cell cycle| |regulation of mitotic cell cycle| |regulation of growth| |chromatin organization| |regulation of cell cycle process| |peptidyl-amino acid modification| |apoptotic process| |programmed cell death| |chromosome organization| |cell death| |regulation of cell cycle| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.13| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.79| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|-1.72| |[[:results:exp261|ABT-702 5μM R06 exp261]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4194 * **Expression level (log2 read counts)**: 7.01 {{:chemogenomics:nalm6 dist.png?nolink |}}